SCHEMBL573731

SCHEMBL573731

COC(=O)c1cc(N)c(Oc2ccccc2)c(S(=O)(=O)N=CN(C)C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 7/20 0.43
ALDH1A1 P00352 6/20 0.43
KDM4E B2RXH2 5/20 0.43
GAA P10253 3/20 0.43
PKM P14618 1/20 0.43
USP2 O75604 3/20 0.38
HSD17B10 Q99714 3/20 0.36
LMNA P02545 3/20 0.36
HIF1A Q16665 2/20 0.36
TSHR P16473 2/20 0.36
CA2 P00918 1/20 0.36
BLM P54132 1/20 0.36
SLC12A2 P55011 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
RAB9A P51151 3/20 0.36
MAPT P10636 2/20 0.36
GLA P06280 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10222901 1.00 HPGD (0.43) HPGDALDH1A1KDM4EGAAPKM
SCHEMBL574175 1.00 HPGD (0.43) HPGDALDH1A1KDM4EGAAPKM
SCHEMBL11004645 0.92 CA1 (0.38) HPGDALDH1A1KDM4EGAAPKM
SCHEMBL11510955 0.91 ALDH1A1 (0.36) HPGDALDH1A1KDM4EGAAPKM
SCHEMBL10998937 0.91 GAA (0.41) HPGDALDH1A1KDM4EGAAPKM
SCHEMBL11512629 0.91 LNPEP (0.45) HPGDALDH1A1KDM4EGAAPKM
SCHEMBL574909 0.90 KDM4E (0.39) HPGDALDH1A1KDM4EGAAPKM
SCHEMBL10224539 0.90 KDM4E (0.39) HPGDALDH1A1KDM4EGAAPKM
SCHEMBL11512665 0.90 ALDH1A1 (0.39) HPGDALDH1A1KDM4EGAAPKM
SCHEMBL574908 0.90 KDM4E (0.39) HPGDALDH1A1KDM4EGAAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598478-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE Neurotherapeutics Pharma, Inc. (US) 2013-06-05 EP disclosed
WO-2013059648-A1 2,3,5 TRISUBSTITUTED ARYL AND HETEROARYL AMINO DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2013-04-25 WO disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 WO disclosed
US-5145867-A NAPHTHYLALKYLAMINO-SUBSTITUTED SULFAMOYLBENZOIC ACID DERIVATIVES, AND THE USE THEREOF AS MEDICINES HOECHST AKTIENGESELLSCHAFT (DE) 1992-09-08 US disclosed
US-4492710-A Substituted pyrrolidinyl-benzoic acid derivatives and a process for their manufacture HOECHST AKTIENGESELLSCHAFT (DE) 1985-01-08 US disclosed
US-4172142-A DIURETICS FOR TREATMENT OF EDEMA HOECHST AKTIENGESELLSCHAFT (DE) 1979-10-23 US disclosed
US-4161531-A Diuretic and saluretic 5-sulfamoylbenzoic acid derivatives carrying a heterocyclic substituent HOECHST AKTIENGESELLSCHAFT (DE) 1979-07-17 US disclosed
US-4118397-A DIURETICS HOECHST AKTIENGESELLSCHAFT (DE) 1978-10-03 US disclosed
US-4111953-A DIURETICS HOECHST AKTIENGESELLSCHAFT (DE) 1978-09-05 US disclosed
US-4093735-A DIURETICS HOECHST AKTIENGESELLSCHAFT (DT) 1978-06-06 US disclosed
US-4010273-A DIURETICS, SALURETICS HOECHST AKTIENGESELLSCHAFT (DT) 1977-03-01 US disclosed